세계의 추체간 고정 기기 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCore

The global interbody fusion market was valued at over $3.1 billion in 2024.

It is projected to grow at a CAGR of 4.3% to surpass $4.2 billion by 2031.

The full report suite includes segmentation for:

• Anterior Lumbar Interbody Fusion (ALIF)
• Posterior Lumbar Interbody Fusion (PLIF)
• Transforaminal Lumbar Interbody Fusion (TLIF)
• Cervical Interbody Fusion (CIF)
• VBR/Corpectomy
• Expandable Interbody Devices

Market Data Included

• Unit Sales
• Average Selling Prices (ASPs)
• Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data to 2024
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

Global Interbody Fusion Device Market Trends

• The primary limiter in the spinal fusion market is the rise of minimally invasive surgical (MIS) interbody devices.
• MIS techniques reduce tissue trauma, lower complication rates, and shorten surgery duration.
• Positive clinical outcomes have fueled adoption in mature markets and are expected to similarly affect emerging markets.
• Preference for MIS over open techniques continues to impact growth potential of traditional interbody devices.

Global Interbody Fusion Device Market Share Insights

• 1 Medtronic
  • Market leader in 2024, with strong dominance in North America and parts of Asia-Pacific.
  • Key products include:
    • Elevate(TM) expandable cage
    • Anatomic(R) PTC and Cornerstone(R) PSR (cervical segment)
    • Capstone(R) cage, Cornerstone L ASR(R), and other bone dowels/wedges
    • ARTiC(TM) line of 3D-printed metal devices
  • Medtronic also leads in VBR and expandable interbody segments.
• 2 DePuy Synthes
  • Second-largest global competitor in 2024.
  • Offers CFRP (carbon fiber reinforced polymer) lumbar interbody cages and various bone/non-bone devices.
  • Strong market presence in Western Europe and Asia-Pacific contributes significantly to its share.
• 3 Globus Medical / NuVasive
  • Major competitor post-2023 merger.
  • Anticipated to gain market share through:
    • Complementary global scale
    • Expanded commercial reach
    • Extensive product portfolio in spine and orthopedics
    • Strong surgeon engagement and R&D investment
  • Combined strengths position the merged entity for continued growth across all interbody subsegments.

Market Segmentation Summary

• Anterior Lumbar Interbody Fusion (ALIF)
• Posterior Lumbar Interbody Fusion (PLIF)
• Transforaminal Lumbar Interbody Fusion (TLIF)
• Cervical Interbody Fusion (CIF)
• VBR/Corpectomy Devices
• Expandable Interbody Devices

Research Scope Summary

• Regions Covered
  • North America: Canada, United States
  • Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
  • Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
  • Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
  • Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
  • Asia Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
  • Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Data

• Procedure Numbers
• Market Size
• Market Shares
• Market Forecasts
• Market Growth Rates
• Units Sold
• Average Selling Prices

Qualitative Data

• Market Growth Trends
• Market Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles
• Product Portfolios
• FDA Recalls
• Disruptive Technologies
• Disease Overviews

Data Sources

• Primary Interviews with Industry Leaders
• Government Physician Data
• Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

Interbody Fusion Market

• 7.1 Executive Summary
  • 7.1.1 Global Interbody Fusion Market Overview
  • 7.1.2 Competitive Analysis
  • 7.1.3 Procedure Segmentation
  • 7.1.4 Market Segmentation
  • 7.1.5 Regions Included
• 7.2 Introduction
  • 7.2.1 ALIF
  • 7.2.2 PLIF
  • 7.2.3 TLIF
  • 7.2.4 CIF
  • 7.2.5 VBR/Corpectomy
• 7.3 Procedure Numbers
  • 7.3.1 Total Interbody Fusion Procedures
  • 7.3.2 ALIF Procedures
  • 7.3.3 PLIF Procedures
  • 7.3.4 TLIF Procedures
  • 7.3.5 CIF Procedures
  • 7.3.6 VBR/Corpectomy Interbody Device Procedures
  • 7.3.7 Expandable Interbody Device Procedures
• 7.4 Market Overview
  • 7.4.1 By Segment
  • 7.4.2 By Region
• 7.5 Market Analysis and Forecast
  • 7.5.1 Total Interbody Fusion Market
  • 7.5.2 ALIF Market
  • 7.5.3 PLIF Market
  • 7.5.4 TLIF Market
  • 7.5.5 CIF Market
  • 7.5.6 VBR/Corpectomy Interbody Device Market
  • 7.5.7 Expandable Interbody Device Market
• 7.6 Drivers and Limiters
  • 7.6.1 Market Drivers
  • 7.6.2 Market Limiters
• 7.7 Competitive Market Share Analysis